COMMUNIQUÉS West-GlobeNewswire

Helix BioPharma Corp. Signs Collaboration Agreement With ProMab Biotechnologies to Co-Develop CAR-T for Hematological Malignancies
21/03/2018
RICHMOND HILL, Ontario, March 21, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP ), (FSE:HBP) (“Helix” or the “Company”), a immuno-oncology company developing innovative drug candidates for the prevention and [...]
Geron to Present at the Needham Healthcare Conference
21/03/2018
MENLO PARK, Calif., March 21, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN ) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present at the 17th Annual [...]
KemPharm, Inc. to Report Fourth Quarter and Year End 2017 Results
21/03/2018
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for March 29th, 2018, 4:30 p.m. ET CORALVILLE, Iowa, March 21, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH ), a specialty pharmaceutical [...]
SuperSonic Imagine’s Aixplorer® Ultimate Highlighted at American Institute of Ultrasound in Medicine Meeting in New York
21/03/2018
Aix-en-Provence, France, March 21, 2018 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext: SSI) (FR0010526814), a company specializing in ultrasound medical imaging, announced today that it will highlight its premium [...]
Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2017 Financial Results
21/03/2018
BERKELEY HEIGHTS, N.J., March 21, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC ) (NASDAQ: CYCCP ) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral therapies that target [...]
Leap Therapeutics to Present at the 2018 Needham & Company 17th Annual Healthcare Conference
21/03/2018
CAMBRIDGE, Mass., March 21, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ: LPTX ), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced that Christopher K. Mirabelli, [...]
Bringing Generations Together Through Music
21/03/2018
DALLAS, March 21, 2018 (GLOBE NEWSWIRE) -- According to research, music and intergenerational interaction 1 can enhance cognitive abilities and quality of life in children 2 , parents, and seniors 3 . As part of its [...]
Nohla Therapeutics Selects Advanced Therapies Business Unit of WuXi AppTec To Manufacture Universal Donor Cell Therapies
21/03/2018
SEATTLE and PHILADELPHIA, March 21, 2018 (GLOBE NEWSWIRE) -- Nohla Therapeutics, a leading developer of universal donor cell therapies for patients with hematologic malignances and other critical diseases, and WuXi [...]
Nabriva Therapeutics Appoints Jennifer Schranz, M.D., as Chief Medical Officer
21/03/2018
DUBLIN, Ireland and KING OF PRUSSIA, Pa., March 21, 2018 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV ), a clinical stage biopharmaceutical company engaged in the research and development of novel anti- [...]
Capricor Therapeutics to Present at Upcoming Oppenheimer and Needham Healthcare Conferences
21/03/2018
LOS ANGELES, March 21, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR ) today announced that it will participate in two upcoming investment banking conferences, Oppenheimer’s 28 th Annual Healthcare [...]
Recro Pharma to Present at the 17th Annual Needham Healthcare Conference
21/03/2018
MALVERN, Pa., March 21, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq: REPH ), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care settings, today [...]
Akari Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results and Highlights Recent Clinical Progress
21/03/2018
Received Regulatory Clearance in Europe to Open First Clinical Trial Site for Phase III PNH Naïve Trial CAPSTONE, the Phase III Naïve PNH Trial Expected to Open in Q1 2018 Phase II PNH Trial Completed With Primary [...]
Fennec Pharmaceuticals Receives Fast Track Designation by FDA for PEDMARK
21/03/2018
RESEARCH TRIANGLE PARK, N.C., March 21, 2018 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC ) (TSX: FRX ), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration ( [...]
EDAP TMS SA : EDAP Announces CIGNA as First Major U.S. Private Health Insurer to Cover HIFU for Prostate Procedure
21/03/2018
Insurer Takes its Cue from Updated NCCN Guidelines, Which Recognizes HIFU as Salvage Treatment for Prostate Cancer Lyon, France, Austin, TX -- March 21, 2018 - EDAP TMS SA (Nasdaq: EDAP) today announced that CIGNA [...]
Amphastar Announces Final Judgment in the Patent Litigation against Momenta Pharmaceuticals, Inc. and Sandoz Inc.
21/03/2018
RANCHO CUCAMONGA, Calif., March 21, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH ) announced that on March 20, 2018, the United States Court for the District of Massachusetts (the “District [...]
PotNetwork Holding Inc. Leadership Appears on The Mick Bazsuly Show, Projects 60-70% Gains in Revenues for 2018
21/03/2018
FORT LAUDERDALE, Fla., March 21, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- PotNetwork Holding Inc. (OTC Pink:POTN) On Tuesday the 20th of March in 2018, PotNetwork Holding Inc. CEO Dr. Richard Goulding and Senior [...]
RavenQuest Obtains OTCQB Listing Under Symbol “RVVQF”
21/03/2018
VANCOUVER, British Columbia, March 21, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE:RQB) (OTCQB:RVVQF) (Frankfurt: 1IT ) is pleased to announce that OTC Markets Group Inc. has [...]
Amarin Announces First Middle East Approval for Vascepa®
21/03/2018
BEDMINSTER, N.J. and DUBLIN, Ireland, March 21, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]
Helsinn Group announces agreement to acquire worldwide rights to Valchlor/Ledaga, an approved and marketed alkylating agent for topical treatment of mycosis fungoides type cutaneous T-cell lymphoma
21/03/2018
Helsinn Group announces agreement to acquire worldwide rights to Valchlor ® /Ledaga ® - an approved and marketed alkylating agent for the topical treatment of mycosis fungoides- type cutaneous T- cell lymphoma, a rare [...]

Pages